Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Elanco

Request full access

Elanco | Solutions for Protecting and Enhancing Animal Health

Indianapolis, United StatesFounded 1954Biotech & Life Sciences

About Elanco

The story of Elanco begins not with a founder, but within a pharmaceutical giant. In 1953, Eli Lilly and Company introduced its first antibiotic for veterinary use. This move laid the groundwork for a new division, and in 1954, the company formally organized its animal science activities, led by George Varnes. The name 'Elanco,' short for Eli Lilly and Company, was officially adopted in 1960. For decades, Elanco operated and grew under the Lilly umbrella, expanding globally and building out its portfolio of products for both livestock and pets. A pivotal moment arrived in September 2018, when Elanco held its Initial Public Offering (IPO) on the New York Stock Exchange. This marked the beginning of its separation from Eli Lilly, and by 2019, Elanco was a fully independent company. Now standing on its own, Elanco made a bold, strategic move. In August 2020, it completed the acquisition of Bayer Animal Health for approximately $6.89 billion. This transaction significantly expanded Elanco's scale, particularly in the companion animal market, and positioned it as the world's second-largest animal health company. The deal combined Elanco's strength with veterinarians with Bayer's direct-to-consumer experience, creating a more diversified and formidable player in the industry.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2018
Employees
9,380
Open positions
232
Dealroom signal
82.2/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology, Innovative Food
Sector
Veterinary, Biotechnology, Biotech and Pharma, Pets, DT and LS, observatoire healthtech, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2C
Investment activity
10 companies, latest Feb 2026
Capital deployed
$22M
Preferred round
ACQUISITION

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO EQUITY✓Other financing Dec 2023 $250M — Ancora ↗
CORPORATE SPINOUT✓Other financing Jan 2019 $0 — Eli Lilly —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Elanco website traffic

Latest recorded traffic for Elanco is 79K monthly website visits, up 17.9% over the last three months. Elanco's team grew 23.7% over the past year.

Latest monthly visits79K 3-month web change+17.9% 1-year team growth+23.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Elanco in the Indianapolis ecosystem

Live from Dealroom

The Elanco office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

  • Eli Lilly
  • Ancora
Team profiled 66 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Indianapolis HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Elanco on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Elanco’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.